Stockreport

Compass Pathways to expedite launch of its experimental depression therapy [Yahoo! Finance]

Cybin Inc. Common Shares  (CYBN) 
PDF of its experimental psilocybin-based depression therapy by 9 to 12 months, sending its shares nearly 6% higher. Following a positive meeting with the U.S. Food and Dru [Read more]